Phathom Pharmaceuticals is a biopharmaceutical company.
Phathom Pharmaceuticals has raised $130.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2026.
Phathom Pharmaceuticals's investors include RA Capital Management, Janus Henderson Investors, New Enterprise Associates, Frazier Healthcare Partners, Hercules Capital.
Phathom Pharmaceuticals is headquartered in Florham Park, United States.
Phathom Pharmaceuticals is a biopharmaceutical company.
Phathom Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Phathom Pharmaceuticals — Funding & Investors." VCBacked, January 7, 2026, https://www.vcbacked.co/company/phathom-pharmaceuticals. Accessed November 12, 2026.
VCBacked. (2026). Phathom Pharmaceuticals — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/phathom-pharmaceuticals
{{cite web |title=Phathom Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/phathom-pharmaceuticals |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Phathom Pharmaceuticals? Request a listing update